Navigation Links
Renhuang Pharmaceuticals Exhibits All-Natural Products at the 63rd PHARMACHINA Fair
Date:5/13/2010

HARBIN, China, May 13 /PRNewswire-Asia-FirstCall/ -- Renhuang Pharmaceuticals, Inc. (Pink Sheets: RHGP) ("Renhuang" or the "Company"), a developer, manufacturer and distributor of botanical products, bio-pharmaceuticals and traditional Chinese medicines ("TCM"), today announced that the Company successfully exhibited its products at the 63rd PHARMACHINA fair("The Fair") held in Xiamen, China.

The PHARMACHINA Fair brought a diverse audience of consumers, distributors, and media to Renhuang's booth to learn more about the Company's innovative all-natural plant-based products. The Company showcased its series products based on Siberian Ginseng (Acanthopanax), which has well-documented benefits for treating depression and anxiety without the side effect often associated with chemical-based drugs. Based on participation at the Fair, Renhuang has secured several new business opportunities which the Company believes will contribute approximately $3.0 million to its fiscal year 2011 revenue.

"Our participation at the 63rd PHARMACHINA Fair was a great success. As the market demand for anti-depressants and nerve-regulating treatments continues to grow, our Siberiana Ginseng-based product series generated significant interest at the Fair," said Mr. Shaoming Li, Chairman and Chief Executive Officer of Renhuang. "We signed several agreements with new distributors and anticipate these deals will positively contribute to our revenue in fiscal 2011. As an increasing number of consumers seek alternatives to expensive chemical-based anti-depressants, we see significant growth opportunity for our cost-effective Siberian Ginseng products with their well-established efficacy and minimal side effects."


'/>"/>
SOURCE Renhuang Pharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related biology technology :

1. Renhuang Pharmaceuticals, Inc. Announces Solid Fourth Quarter and Fiscal Year 2007 Results
2. Vion Pharmaceuticals Pays Interest on 7.75% Convertible Senior Notes
3. China Biopharmaceuticals Holdings Announces Second Quarter 2007 Financial Results
4. Vion Pharmaceuticals Completes Accrual of 85 Patients to its Pivotal Phase II Trial of Cloretazine(R) (VNP40101M) in Elderly AML
5. XTL Biopharmaceuticals Announces Financial Results for the Six Months Ended June 30, 2007
6. Cadence Pharmaceuticals Reports Second Quarter 2007 Financial Results
7. Nabi Biopharmaceuticals to Present at Upcoming Industry Conferences
8. Anadys Pharmaceuticals Appoints Steve Worland, Ph.D. as President and Chief Executive Officer
9. Poniard Pharmaceuticals Announces Participation in Upcoming Conferences
10. NovaQuest Advances Virtual Development Model With Strategic Investment in TOPIGEN Pharmaceuticals
11. Drug Royalty Corporation (DRC) Announces Acquisition Regarding PEG-INTRON(R) From Enzon Pharmaceuticals, Inc. (ENZN)
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/21/2015)... , May 21, 2015 ... inner feelings - and those of others. Being able ... senses. Analyze and read people to anticipate their thoughts ... your deepest emotions and feelings to create unique abstract ... of responsive games. Get inside a first-person-shooter as it ...
(Date:5/21/2015)... Patent Offering, The patent’s technology pertains to ... imaging within a body lumen (open space). Known ... low cost, single-use disposable illumination and camera module (housing). ... 2013 and the patent approval was received on January ... customize the lighting and magnification of the endoscope for ...
(Date:5/21/2015)... 2015 As part of its philanthropic ... Sun Health Foundation funded a $3.25 million project to ... with the most up-to-date features and technology. , The ... pharmacy's 45 staff members will begin moving from the ... the coming days. , The current pharmacy has ...
(Date:5/21/2015)... 21, 2015 /PRNewswire/ - RepliCel Life Sciences Inc. ... medicine company focused on the development of autologous ... at the International Society for Cellular Therapy (ISCT) ... tendinosis currently in a Phase 1/2 clinical trial.  ... from 5:30 PM to 7:00 PM local ...
Breaking Biology Technology:5 Days to Meet ARGUS - The World's First Contactless Emotions Scanner 2IpAuctions™ Presents The Worlds Smallest Disposable Illuminated Endoscope For Auction 2IpAuctions™ Presents The Worlds Smallest Disposable Illuminated Endoscope For Auction 3Sun Health Foundation Provides $3.25M to Expand, Relocate Banner Del E. Webb Medical Center Pharmacy 2Sun Health Foundation Provides $3.25M to Expand, Relocate Banner Del E. Webb Medical Center Pharmacy 3RepliCel to Present Unique Autologous Cell Treatment for Achilles Tendinosis at International Society for Cellular Therapy Conference 2RepliCel to Present Unique Autologous Cell Treatment for Achilles Tendinosis at International Society for Cellular Therapy Conference 3
... NEW YORK , June 21 Reportlinker.com ... its catalogue: , , ... Molecular Diagnostics Market: DNA Probes and Biochips ... Instrument and Reagent Suppliers , ...
... /PRNewswire-FirstCall/ - Aeterna Zentaris Inc. (NASDAQ: AEZS ... company specialized in oncology and endocrinology, announced today that ... of US$12.1 million of units comprised of ... institutional investors. Net proceeds from this offering, after deducting ...
... DALLAS, Texas , June 21, 2010 The Pharmaceuticals ... Market (2010 -2015). , , , ... Browse in-depth TOC on World Low Calorie/Diet Beverages Market (2010,-2015)Market Report. Early ... , , ...
Cached Biology Technology:Reportlinker Adds Molecular Diagnostics Market: DNA Probes and Biochips -- New Product Development Opportunities and Business Expansion Strategies for Instrument and Reagent Suppliers 2Reportlinker Adds Molecular Diagnostics Market: DNA Probes and Biochips -- New Product Development Opportunities and Business Expansion Strategies for Instrument and Reagent Suppliers 3Reportlinker Adds Molecular Diagnostics Market: DNA Probes and Biochips -- New Product Development Opportunities and Business Expansion Strategies for Instrument and Reagent Suppliers 4Reportlinker Adds Molecular Diagnostics Market: DNA Probes and Biochips -- New Product Development Opportunities and Business Expansion Strategies for Instrument and Reagent Suppliers 5Reportlinker Adds Molecular Diagnostics Market: DNA Probes and Biochips -- New Product Development Opportunities and Business Expansion Strategies for Instrument and Reagent Suppliers 6Aeterna Zentaris Receives US$12 Million on Closing of Registered Direct Offering 2Aeterna Zentaris Receives US$12 Million on Closing of Registered Direct Offering 3World Low Calorie/Diet Beverages Market (2010 -2015): MarketsandMarkets 2World Low Calorie/Diet Beverages Market (2010 -2015): MarketsandMarkets 3
(Date:4/20/2015)... PASADENA, Calif. , April 20, 2015 ... San Gabriel Valley to implant a new miniaturized, wireless ... HF System is the first and only FDA-approved heart ... reduce hospital admissions when used by physicians to manage ... a sensor that is implanted in the pulmonary artery ...
(Date:4/14/2015)... 14, 2015  HYPR Corp. today announced it ... ) Alliance tm , an industry consortium transforming ... to share technology and collaborate to deliver open ... more secure and private, and easier to use. ... that protects sensitive user information and eliminates the ...
(Date:4/13/2015)... a leading cloud-based consumer engagement platform that provides trusted ... communities around health and wellness, announced today the launching ... The ... vehicle to receive validated health information from consumers. ... will allow higi,s trusted partners, on a user opt-in ...
Breaking Biology News(10 mins):Huntington Memorial Hospital Becomes First in the San Gabriel Valley to Offer Patients a New Heart Failure Monitoring Solution 2Huntington Memorial Hospital Becomes First in the San Gabriel Valley to Offer Patients a New Heart Failure Monitoring Solution 3HYPR Corp. Joins the FIDO Alliance 2HYPR Corp. Joins the FIDO Alliance 3higi Launches Seamless Access to HIPAA-Compliant Health Outcomes and Activity Data 2higi Launches Seamless Access to HIPAA-Compliant Health Outcomes and Activity Data 3
... senior scientist at the Marshall Institute for Interdisciplinary Research (MIIR), ... of Health to lead a project to develop a technique ... The project will combine the expertise of two research groups ... growth and development, and his team at MIIR will be ...
... This news release is available in German ... reported in the current issue of the " Journal of Clinical ... repair mechanisms begin to fail with increasing age. As a result, ... diseases, including Alzheimer,s disease, diabetes, cardiovascular disorders and cancer, increases. "Current ...
... in the journal Nature reveals for the first ... can change sea surface temperatures on seasonal and longer timescales. ... ocean that takes up heat from the atmosphere, these changes ... a new measurement of mixing, Jim Moum and Jonathan Nash ...
Cached Biology News:MIIR scientist awarded $293,000 NIH grant 2Rapamycin: Limited anti-aging effects 2Rapamycin: Limited anti-aging effects 3Study explains Pacific equatorial cold water region 2Study explains Pacific equatorial cold water region 3